HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD

Abstract : In patients with COPD, there is controversy regarding the association of blood eosinophil (Eos) levels with 1) exacerbation frequency and 2) the effect of inhaled corticosteroids for prevention of exacerbations. To determine whether Eos define subgroups of patients exhibiting attributes of COPD clinical phenotypes, we compared clinical features and mortality rates in COPD patients from the Initiatives BPCO French cohort categorized using different thresholds of blood Eos levels. The following data were collected at inclusion: medical and smoking history, occupational exposures, dyspnea, cough and sputum production, exacerbations in the previous year, history of allergy and asthma, nasal symptoms, body mass index, St George Respiratory Questionnaire (SGRQ) total score, post-bronchodilator spirometry, comorbidities, and medications. Three-year survival between groups was compared using Kaplan–Meier analysis. Three sets of analyses were performed to compare patients with ≥2% versus <2%, ≥3% versus <3%, and ≥4% versus <4% Eos. Eos was available in 458 patients (mean age: 62 years, 72% male, mean forced expiratory volume in 1 second: 51% pred), including 235 patients with Eos ≥2% (49%), 149 with Eos ≥3% (33%), and 90 with Eos ≥4% (20%). For all cutoffs, there was no difference between Eos+ and Eos- groups in univariate analyses except for diabetes and SGRQ score (more frequent and more impaired, respectively, in lower Eos categories). In particular, there was no difference in exacerbation rate, history of asthma, or three-year survival. In conclusion, regardless of the cutoff, Eos+ COPD patients exhibited no specific characteristic in terms of symptoms, lung function, exacerbation rate, and prognosis. These findings suggest that the association of higher Eos with exacerbations reported in previous studies could be population specific, which does not support generalizing the use of Eos as a biomarker for COPD phenotyping.
Complete list of metadata

Contributor : Valerian Dormoy Connect in order to contact the contributor
Submitted on : Monday, February 1, 2021 - 12:37:22 PM
Last modification on : Monday, February 7, 2022 - 2:50:29 PM
Long-term archiving on: : Sunday, May 2, 2021 - 7:13:22 PM


Publisher files allowed on an open archive



Maéva Zysman, Gaetan Deslée, Denis Caillaud, Pascal Chanez, Roger Escamilla, et al.. Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease, Dove Medical Press, 2017, 12, pp.1819-1824. ⟨10.2147/COPD.S129787⟩. ⟨hal-02451026⟩



Record views


Files downloads